These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6658185)

  • 1. Stoichiometry of calcium binding by hypoglycemic sulfonylureas.
    Deleers M; Brasseur R; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):181-201. PubMed ID: 6658185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ionophoretic activity of hypoglycemic sulfonylureas.
    Couturier E; Malaisse WJ
    Arch Int Pharmacodyn Ther; 1980 Jun; 245(2):323-34. PubMed ID: 6250506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of hypoglycemic sulfonylureas and negative phospholipids on calcium transport: ionic and conformational aspects.
    Deleers M; Grognet P; Mahy M; Brasseur R; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):407-24. PubMed ID: 6635329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Ca2+ ionophoretic activity of hypoglycemic sulfonylureas in excitable cells and isolated secretory granules.
    Gylfe E; Hellman B
    Mol Pharmacol; 1982 Nov; 22(3):715-20. PubMed ID: 7155128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protonophoretic activity of hypoglycemic sulfonylureas in black lipid membranes.
    Deleers M; Brasseur R
    Pharmacol Res Commun; 1986 Feb; 18(2):129-36. PubMed ID: 3010341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ionophoretic properties of the non-sulfonylurea hypoglycemic agents A-4166 and KAD-1229.
    Bakkali-Nadi A; Malaisse-Lagae F; Malaisse WJ
    Res Commun Mol Pathol Pharmacol; 1995 Jun; 88(3):339-47. PubMed ID: 8564389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
    Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T
    Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonylurea and glinide reduce insulin content, functional expression of K(ATP) channels, and accelerate apoptotic beta-cell death in the chronic phase.
    Takahashi A; Nagashima K; Hamasaki A; Kuwamura N; Kawasaki Y; Ikeda H; Yamada Y; Inagaki N; Seino Y
    Diabetes Res Clin Pract; 2007 Sep; 77(3):343-50. PubMed ID: 17316868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous calcium preconditions myocardium from patients taking oral sulfonylurea agents.
    Cain BS; Meldrum DR; Meng X; Pulido EJ; Shames BD; Selzman CH; Banerjee A; Harken AH
    J Surg Res; 1999 Oct; 86(2):171-6. PubMed ID: 10534420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homologous and hybrid calcium complexes of A23187 and hypoglycemic sulfonylureas: nuclear magnetic resonance and conformational analysis.
    Deleers M; Brasseur R; Gelbcke M; Malaisse WJ
    J Inorg Biochem; 1982 Jun; 16(3):215-25. PubMed ID: 6809893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical study on conformation-related activity of hypoglycemic sulfonylureas.
    Brasseur R; Deleers M
    Pharmacol Res Commun; 1983 Nov; 15(10):901-7. PubMed ID: 6336538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ionophoretic property of hypoglycemic sulfonylureas: competition between H+ and Ca2+.
    Deleers M; Couturier E; Mahy M; Gelbcke M; Malaisse WJ
    Ann Endocrinol (Paris); 1981; 42(3):297-9. PubMed ID: 7316466
    [No Abstract]   [Full Text] [Related]  

  • 13. Ionophoretic activity of meglitinide analogues.
    Bakkali-Nadi A; Malaisse-Lagae F; Malaisse WJ
    Diabetes Res; 1994; 27(2):61-71. PubMed ID: 7671555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycemic compounds. Amino acid derivatives of sulfonylurea. II.
    Vicentini CB; Guarneri M; Sarto G
    Farmaco Sci; 1983 Sep; 38(9):672-8. PubMed ID: 6641933
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergistic effects of hypoglycaemic sulphonylureas and antibiotic ionophores upon calcium translocation.
    Couturier E; Malaisse WJ
    Br J Pharmacol; 1980; 71(1):315-20. PubMed ID: 6781574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational analysis of the calcium complexes formed by meglitinide analogs.
    Lins L; Brasseur R; Malaisse WJ
    Res Commun Mol Pathol Pharmacol; 1995 Oct; 90(1):153-64. PubMed ID: 8581340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sulfonylurea-induced hypoglycemia. An iatrogenic and potentially fatal condition].
    Carlsen SM
    Tidsskr Nor Laegeforen; 1997 Sep; 117(21):3079-82. PubMed ID: 9381441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sulfonylureas on mitochondrial ATP-sensitive K+ channels in cardiac myocytes: implications for sulfonylurea controversy.
    Sato T; Nishida H; Miyazaki M; Nakaya H
    Diabetes Metab Res Rev; 2006; 22(5):341-7. PubMed ID: 16444778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A short series of antidiabetic sulfonylureas exhibit multiple ligand PPARgamma-binding patterns.
    Arrault A; Rocchi S; Picard F; Maurois P; Pirotte B; Vamecq J
    Biomed Pharmacother; 2009 Jan; 63(1):56-62. PubMed ID: 18280694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New compounds and reactions of sulfonamides with amines. XVI. Preparation and study of hypoglycemic activity of some derivatives of N-(benzenesulfonyl)-N'[(1-pyrazolyl) -alkyl] urea].
    Brzozowski Z; Pac-Pomarnacka E; Dekarz B; Angielski S; Wójcikowski C
    Acta Pol Pharm; 1976; 33(4):461-7. PubMed ID: 970168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.